Evasion Mechanisms to Igf1r Inhibition in Rhabdomyosarcoma

Inhibition of the insulin-like growth factor 1 receptor (Igf1r) is an approach being taken in clinical trials to overcome the dismal outcome for metastatic alveolar rhabdomyosarcoma (ARMS), an aggressive muscle cancer of children and young adults. In our study, we address the potential mechanism(s)...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Abraham, Jinu, Prajapati, Suresh I., Nishijo, Koichi, Schaffer, Beverly S., Taniguchi, Eri, Kilcoyne, Aoife, McCleish, Amanda T., Nelon, Laura D., Giles, Francis G., Efstratiadis, Argiris, LeGallo, Robin D., Nowak, Brent M., Rubin, Brian P., Malempati, Suman, Keller, Charles
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4109806/
https://ncbi.nlm.nih.gov/pubmed/21447712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-10-0695
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller